THE WHITE HOUSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : THE WHITE HOUSE

SPY 680.44

+0.6%

Dec 19 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stan who wrote (17761)	2/28/2008 10:22:03 PM
From: Gersh Avery	Read Replies (1) of 25737

Researchers of the Hadassah University Hospital of Jerusalem investigated the effects of the plant cannabinoid cannabidiol (CBD) on the development of diabetes in mice, which develop diabetes due to genetic causes. So-called NOD mice develop insulitis within 4 to 5 weeks of age followed by diabetes within a median of 14 weeks. Insulitis is an inflammation of the cells in the pancreas that produce insulin, and diabetes is a result of a destruction of these cells. NOD mice aged 6 to 12 weeks that were treated with 10 to 20 injections of CBD (5 mg per kilogram body weight) presented with a significantly reduced incidence of diabetes of 30 per cent compared to 86 per cent in untreated control mice. In addition, in the mice that developed diabetes in the treated group disease onset was a significantly delayed. Blood levels of two cytokines that promote inflammation, IFN-gamma and TFN-alpha, are usually increased in NOD mice. A treatment with CBD caused a significant reduction (more than 70 per cent) in levels of both cytokines. In another experiment CBD-treated mice were observed for 26 weeks. While the 5 control mice all developed diabetes, 3 of 5 of the CBD-treated mice remained diabetes-free at 26 weeks. Researchers concluded that confirmation of the observed immunomodulatory effects of CBD "may lead to the clinical application of this agent in the prevention of type 1 diabetes" and possibly other autoimmune diseases. They note that many patients diagnosed with type 1 diabetes have sufficient residual cells that produce insulin at the time of diagnosis, and may be candidates for immunomodulation therapy. ---------------------- end quote -------------------------------- CBD is only found in marijuana. It does not get you high. Most of the high grade black market marijuana has had nearly all of the CBD bread out of it by Dutch seed breaders. These strains have raised the THC content by lowering the CBD content. There are many underground efforts in the US which are trying to produce strains that have the natural CBD content returned. There has been some success. CBD also works for type 2 diabetes. Perhaps better than type 1. Diabetes Cannabinoid Reduces Incidence Of Diabetes norml.org Marijuana Compound May Help Stop Diabetic Retinopathy sciencedaily.com Cannabidiol lowers incidence of diabetes in non-obese diabetic mice ingentaconnect.com Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model level1diet.com Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol ajp.amjpathol.org The Cannabinergic System as a Target for Anti-inflammatory Therapies ingentaconnect.com Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes unboundmedicine.com Cannabidiol reduces the development of diabetes in an animal study cannabis-med.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next